Mutations that cause EGFR upregulation are associated with cancer, with EGFR mutations present in 12-38% of lung adenocarcinomas, the main form of non-small cell lung cancer (NSCLC) (4). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.